mitomycin has been researched along with Esophageal Diseases in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
Excerpt | Relevance | Reference |
---|---|---|
"7 % high dose), while both TGF-β3 dosage groups showed no significant change (65." | 1.40 | Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures. ( Chak, A; Cipriano, C; Lash, RH; Marks, JM; Ponsky, JL; Schomisch, SJ; Wu, Y, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, Y | 1 |
Schomisch, SJ | 1 |
Cipriano, C | 1 |
Chak, A | 1 |
Lash, RH | 1 |
Ponsky, JL | 1 |
Marks, JM | 1 |
1 other study available for mitomycin and Esophageal Diseases
Article | Year |
---|---|
Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.
Topics: Angiogenesis Inhibitors; Animals; Cicatrix; Disease Models, Animal; Dissection; Drug Therapy, Combin | 2014 |